Terms: = Testicular cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Prognosis
27 results:
1. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
2. Silencing of LINC00467 inhibits cell proliferation in testicular germ cell tumors cells.
Zhu F; Liu Z; Zhou Q; Zhou D; Fan J; Bo H; Fan L
Biomol Biomed; 2023 Sep; 23(5):802-814. PubMed ID: 37078359
[TBL] [Abstract] [Full Text] [Related]
3. Sperm Autoantigenic Protein 17 Predicts the prognosis and the Immunotherapy Response of cancers: A Pan-cancer Analysis.
Tu Z; Peng J; Long X; Li J; Wu L; Huang K; Zhu X
Front Immunol; 2022; 13():844736. PubMed ID: 35592314
[TBL] [Abstract] [Full Text] [Related]
4. Multiparametric Framework Magnetic Resonance Imaging Assessment of Subtypes of Intracranial Germ Cell Tumors Using Susceptibility Weighted Imaging, Diffusion-Weighted Imaging, and Dynamic Susceptibility-Contrast Perfusion-Weighted Imaging Combined With Conventional Magnetic Resonance Imaging.
Li Y; Wang P; Zhang J; Li J; Chen L; Qiu X
J Magn Reson Imaging; 2022 Oct; 56(4):1232-1242. PubMed ID: 35278008
[TBL] [Abstract] [Full Text] [Related]
5. Proteomic profiling of cisplatin-resistant and cisplatin-sensitive germ cell tumour cell lines using quantitative mass spectrometry.
Fichtner A; Bohnenberger H; Elakad O; Richter A; Lenz C; Oing C; Ströbel P; Kueffer S; Nettersheim D; Bremmer F
World J Urol; 2022 Feb; 40(2):373-383. PubMed ID: 35084545
[TBL] [Abstract] [Full Text] [Related]
6. Hypomethylation-driven AKT Serine/Threonine Kinase 3 promotes testicular germ cell tumors proliferation and negatively correlates to immune infiltration.
Luo Y; Zhou Q; Zhu F; Fan L; Bo H; Wang X
Bioengineered; 2021 Dec; 12(2):11288-11302. PubMed ID: 34882061
[TBL] [Abstract] [Full Text] [Related]
7. Toll-like receptor 2 (TLR2) is a candidate prognostic factor in testicular germ cell tumors as well as an indicator of immune function in the tumor microenvironment.
Wu H; Zhang Z; Xiao XY; Zhang ZY; Gao SL; Lu C; Zuo L; Zhang LF
Bioengineered; 2021 Dec; 12(1):1939-1951. PubMed ID: 34002664
[TBL] [Abstract] [Full Text] [Related]
8. Different chemokine profile between systemic and testicular diffuse large B-cell lymphoma.
Ollikainen RK; Kotkaranta PH; Kemppainen J; Teppo HR; Kuitunen H; Pirinen R; Turpeenniemi-Hujanen T; Kuittinen O; Kuusisto MEL
Leuk Lymphoma; 2021 Sep; 62(9):2151-2160. PubMed ID: 33856274
[TBL] [Abstract] [Full Text] [Related]
9. Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium.
Gillessen S; Sauvé N; Collette L; Daugaard G; de Wit R; Albany C; Tryakin A; Fizazi K; Stahl O; Gietema JA; De Giorgi U; Cafferty FH; Hansen AR; Tandstad T; Huddart RA; Necchi A; Sweeney CJ; Garcia-Del-Muro X; Heng DYC; Lorch A; Chovanec M; Winquist E; Grimison P; Feldman DR; Terbuch A; Hentrich M; Bokemeyer C; Negaard H; Fankhauser C; Shamash J; Vaughn DJ; Sternberg CN; Heidenreich A; Beyer J;
J Clin Oncol; 2021 May; 39(14):1563-1574. PubMed ID: 33822655
[TBL] [Abstract] [Full Text] [Related]
10. Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium.
Beyer J; Collette L; Sauvé N; Daugaard G; Feldman DR; Tandstad T; Tryakin A; Stahl O; Gonzalez-Billalabeitia E; De Giorgi U; Culine S; de Wit R; Hansen AR; Bebek M; Terbuch A; Albany C; Hentrich M; Gietema JA; Negaard H; Huddart RA; Lorch A; Cafferty FH; Heng DYC; Sweeney CJ; Winquist E; Chovanec M; Fankhauser C; Stark D; Grimison P; Necchi A; Tran B; Heidenreich A; Shamash J; Sternberg CN; Vaughn DJ; Duran I; Bokemeyer C; Patrikidou A; Cathomas R; Assele S; Gillessen S;
J Clin Oncol; 2021 May; 39(14):1553-1562. PubMed ID: 33729863
[TBL] [Abstract] [Full Text] [Related]
11. Identification of new biomarkers in immune microenvironment of testicular germ cell tumour.
Song Y; Qi X; Kang J; Wang X; Ou N; Zhu J; Wang S; Liu X
Andrologia; 2021 Apr; 53(3):e13986. PubMed ID: 33544925
[TBL] [Abstract] [Full Text] [Related]
12. A model based on tumor-infiltrating immune cells for predicting the relapse rates of patients with testicular germ cell tumors.
Wang Y; Ji C; Liu J; Wang Y; Song N; Cao P
Int Immunopharmacol; 2020 Sep; 86():106710. PubMed ID: 32652500
[TBL] [Abstract] [Full Text] [Related]
13. testicular cancer: improving outcomes with national quality performance indicators.
Baxter MA; MacDonald G; Malik J; Law A; Dahle-Smith Å; Mmeka W; Donat R; Shukla C; Connor J; Houston C; Waterston A; White J
BMJ Open Qual; 2020 Mar; 9(1):. PubMed ID: 32213550
[TBL] [Abstract] [Full Text] [Related]
14. The utility of De Ritis Ratio in predicting prognosis in testicular cancer.
Guner E; Seker KG; Arikan Y; Huseynov C; Sam E; Ozdal OL
Aktuelle Urol; 2020 Jun; 51(3):285-289. PubMed ID: 32135561
[TBL] [Abstract] [Full Text] [Related]
15. testicular cancer Biomarkers: A Role for Precision Medicine in testicular cancer.
Leão R; Ahmad AE; Hamilton RJ
Clin Genitourin Cancer; 2019 Feb; 17(1):e176-e183. PubMed ID: 30497810
[TBL] [Abstract] [Full Text] [Related]
16. Systemic immune-inflammation index in germ-cell tumours.
Chovanec M; Cierna Z; Miskovska V; Machalekova K; Kalavska K; Rejlekova K; Svetlovska D; Macak D; Spanik S; Kajo K; Babal P; De Giorgi U; Mego M; Mardiak J
Br J Cancer; 2018 Mar; 118(6):831-838. PubMed ID: 29485980
[TBL] [Abstract] [Full Text] [Related]
17. Clinical Outcomes of Metastatic Poor prognosis Germ Cell Tumors: Current Perspective From a Referral Center.
Necchi A; Farè E; Vullo SL; Giannatempo P; Raggi D; Nicolai N; Piva L; Biasoni D; Catanzaro M; Torelli T; Stagni S; Maffezzini M; Verzoni E; Grassi P; Procopio G; Pizzocaro G; Mariani L; Salvioni R
Clin Genitourin Cancer; 2015 Aug; 13(4):385-391.e1. PubMed ID: 25726505
[TBL] [Abstract] [Full Text] [Related]
18. Expression profiles of PIWIL2 short isoforms differ in testicular germ cell tumors of various differentiation subtypes.
Gainetdinov IV; Skvortsova YV; Stukacheva EA; Bychenko OS; Kondratieva SA; Zinovieva MV; Azhikina TL
PLoS One; 2014; 9(11):e112528. PubMed ID: 25384072
[TBL] [Abstract] [Full Text] [Related]
19. Impact of hemiscrotectomy on outcome of patients with embryonal paratesticular rhabdomyosarcoma: results from the Cooperative Soft Tissue Sarcoma Group Studies CWS-86, 91, 96 and 2002P.
Seitz G; Dantonello TM; Kosztyla D; Klingebiel T; Leuschner I; Fuchs J; Koscielniak E;
J Urol; 2014 Sep; 192(3):902-7. PubMed ID: 24631108
[TBL] [Abstract] [Full Text] [Related]
20. [Effectiveness of treatment of single cerebral metastasis depending on prognostic groups (RPA RTOG)].
Mikhina ZP; Tkachëv SI; Trofimova OP; Ivanov SM; Medvedev SV; Zakharov SN; Krat VB; Korgunov SV
Vopr Onkol; 2009; 55(2):205-9. PubMed ID: 19514377
[TBL] [Abstract] [Full Text] [Related]
[Next]
